These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16260188)

  • 1. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal time-points in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Med; 2005 Dec; 24(24):3743-56. PubMed ID: 16320272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal designs for clinical trials with second-order polynomial treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2007 Dec; 16(6):523-37. PubMed ID: 17698939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of internal pilots with the univariate approach to repeated measures.
    Coffey CS; Muller KE
    Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.
    Winkens B; van Breukelen GJ; Schouten HJ; Berger MP
    Contemp Clin Trials; 2007 Nov; 28(6):713-9. PubMed ID: 17524958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample sizes in the multivariate analysis of repeated measurements.
    Vonesh EF; Schork MA
    Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
    Correa JA; Bellavance F
    Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal designs for empirical bayes estimators of individual linear and quadratic growth curves in linear mixed models.
    Candel MJ
    Stat Methods Med Res; 2009 Aug; 18(4):397-419. PubMed ID: 19036913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-optimal cohort designs for linear mixed-effects models.
    Tekle FB; Tan FE; Berger MP
    Stat Med; 2008 Jun; 27(14):2586-600. PubMed ID: 17726724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal design of multi-subject blocked fMRI experiments.
    Maus B; van Breukelen GJ; Goebel R; Berger MP
    Neuroimage; 2011 Jun; 56(3):1338-52. PubMed ID: 21406234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient!
    van Breukelen GJ; Candel MJ
    J Clin Epidemiol; 2012 Nov; 65(11):1212-8. PubMed ID: 23017638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements.
    Vangeneugden T; Laenen A; Geys H; Renard D; Molenberghs G
    Control Clin Trials; 2004 Feb; 25(1):13-30. PubMed ID: 14980746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On power and sample size calculation for QT studies with recording replicates at given time point.
    Chow SC; Cheng B; Cosmatos D
    J Biopharm Stat; 2008; 18(3):483-93. PubMed ID: 18470757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches.
    Vickers AJ
    Psychosom Med; 2005; 67(4):652-5. PubMed ID: 16046383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Med; 2007 Jun; 26(13):2589-603. PubMed ID: 17094074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data.
    Shults J; Sun W; Tu X; Kim H; Amsterdam J; Hilbe JM; Ten-Have T
    Stat Med; 2009 Aug; 28(18):2338-55. PubMed ID: 19472307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.